Worldwide Epidemiology and Risk for International Travelers

  • Giampiero Carosi
  • Francesco Castelli


More than 20 years have elapsed since June 5, 1981, when a description of what was later called “acquired immunodeficiency syndrome” was first reported in five young homosexuals in the Morbidity and Mortality Weekly Report [1].


Polysaccharide Vaccine Destination Area Yellow Fever Vaccine Yellow Fever Vaccination Sexual Route 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Gottlieb MS, Schanker HM, Fan PT, et al(1981) Pneumocystis pneumonia—Los Angeles. MMWR 30:20–22Google Scholar
  2. 2.
    World Health Organization (2001) Global situation of the HIV/AIDS pandemic, end 2001. WER 76:381–388Google Scholar
  3. 3.
    Gray RH, Wawer MJ, Brookmeyer R, et al(2001) Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-i discordant couples in Rakai, Uganda. Lancet 357:1149–1153PubMedCrossRefGoogle Scholar
  4. 4.
    Downs A, Heisterkamp SH, Rava L, et al(2000) Back-calculation by birth cohort, incorporating age-specific disease progression, pre-AIDS mortality and change in European AIDS case definition. AIDS 14:2179–2189PubMedCrossRefGoogle Scholar
  5. 5.
    Centro Operativo AIDS (2001) Aggiornamento dei casi AIDS notificati al 30 giugno 2001. Commissione Nazionale Lotta AIDS, 2001Google Scholar
  6. 6.
    McFarland W, Katz MH, Stoyanoff SR, et al(2001) HIV incidence among young men who have sex with men—Seven U.S. cities, 1994-2000. MMWR 50: 440–444Google Scholar
  7. 7.
    Simon V, Vanderhoeven J, Hurley A, et al (2001) Prevalence of Drug-Resistant HIV-1 Variants in Newly Infected Individuals during 1999-2000. 8th Conference on Retroviruses and Opportunistic Infections, 2001, abstract no. 423Google Scholar
  8. 8.
    Castelli F, Patroni A (2001) The human immunodeficiency virus-infected traveler. Clin Inf Dis 31: 1403–1408CrossRefGoogle Scholar
  9. 9.
    Kemper CA, Linett A, Kane C, Deresinsky SC (1995) Frequency of travel of adults infected with HIV. J Travel Med 2:85–88PubMedCrossRefGoogle Scholar
  10. 10.
    Simons FM, Cobelens FG, Danner SA (1999) Common health problems in HIV-infected travelers to the sub-tropics. J Travel Med 6:71–75PubMedCrossRefGoogle Scholar
  11. 11.
    O’Brien W, Grovit-Ferbas K, Namazi A, et al(1995) Human immunodeficiency virus type-i replication can be increased in peripheral blood of seropositive patients after influenza vaccination. Blood 86: 1082–1089PubMedGoogle Scholar
  12. 12.
    Sullivan PS, Hanson DL, Dworkin MS, et al(2000) Effect of influenza vaccination on disease progression among HIV-infected persons. AIDS 14:2781–2785PubMedCrossRefGoogle Scholar
  13. 13.
    Moore D, Nelson M, Henderson D (1998) Pneumococcal vaccination and HIV infection. Int J STD & AIDS 9:1–7Google Scholar
  14. 14.
    Poynard T, Bedossa P, Opolon P, et al(1997) Natural history of liver fibrosis progression in patients with chronic hepatitis C Lancet 349:825–832PubMedCrossRefGoogle Scholar
  15. 15.
    Goujon C, Tohr M, Feuillie V, et al(1995) Good tolerance and efficacy of yellow fever vaccine among carriers of human immunodeficiency virus. J Travel Med 2:145Google Scholar
  16. 16.
    French N, Nakiyingi J, Carpenter LM, et al(2000) 23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomized and placebo-controlled trial. Lancet 355:2106–2111PubMedCrossRefGoogle Scholar
  17. 17.
    Whitworth J, Morgan D, Quigley M, et al(2000) Effect of HIV-i and increasing immunosuppression on malaria parasitaemia and clinical episodes in adults in rural Uganda: a cohort study. Lancet 356:1051–1056PubMedCrossRefGoogle Scholar
  18. 18.
    Kamya MR, Kigonya CN, McFarland W (2001) HIV infection may adversely affect clinical response to chloroquine therapy for uncomplicated malaria in children. AIDS 15:1187–1188PubMedCrossRefGoogle Scholar
  19. 19.
    Khaliq Y, Gallicano K, Tisdale C, et al(2001) Pharmacokinetic interactions between mefloquine and ritonavir in healthy volunteers. Br J Clin Pharmacol 51:591–600PubMedCrossRefGoogle Scholar
  20. 20.
    Schippers EF, Hugen PWH, Hartigh MW, et al(2000) No drug-drug interaction between nelfinavir or indinavir and mefloquine in HIV-1 infected patients. AIDS 14:2794–2795PubMedCrossRefGoogle Scholar
  21. 21.
    Kemper CA, Linett A, Kane C, et al(1997) Travels with HIV: the compliance and health of HIV-infected adults who travel. Int J STD & AIDS 8:44–49CrossRefGoogle Scholar
  22. 22.
    French N, Nakiyingi J, Lugada E, et al(2001) Increasing rate of malaria fever with deteriorating immune status in HIV-infected Ugandan adults. AIDS 15:899–906PubMedCrossRefGoogle Scholar
  23. 23.
    Colebunders R, Nachega J, Van Gompel A (1999) Antiretroviral treatment and travel to developing countries. J Travel Med 6:27–31PubMedCrossRefGoogle Scholar
  24. 24.
    Op de Coul ELN, Coutinho RA, van Doornum GJJ, et al (2001) The impact of immigration on env HIV-1 subtype distribution among heterosexuals in The Netherlands: influx of subtype B and non-B strains. AIDS 15:2277–2286PubMedCrossRefGoogle Scholar
  25. 25.
    Carter S, Horn K, Hart G, et al(1997) The sexual behaviour of international travellers at two Glasgow GUM Clincis. Int J STD & AIDS 8:336–338CrossRefGoogle Scholar
  26. 26.
    Williams ML, Zhao Z, Bowen AM, et al(1997) Introduction of HIV into drug injector networks outside AIDS epicentres. Int J STD & AIDS 8:629–635CrossRefGoogle Scholar
  27. 27.
    MAYISHA Research Team (2001) HIV transmission risk among sub-Saharan Africans in London travelling to their countries of origin. AIDS 15:1442–1444CrossRefGoogle Scholar
  28. 28.
    Morris M, Wawer MJ, Makumbi F, et al(2000) Condom acceptance is higher among travellers in Uganda. AIDS 15:733–741CrossRefGoogle Scholar
  29. 29.
    Mulhall BP (1996) Sex and travel: studies of sexual behaviour, disease and health promotion in international travellers. Int J STD & AIDS 7:455–465CrossRefGoogle Scholar
  30. 30.
    Jones ME (1999) HIV and the returning expatriate. J Travel Med 6:99–106PubMedCrossRefGoogle Scholar
  31. 31.
    Thomson MM, Najera R (2001) Travel and the introduction of human immunodeficiency virus type 1 non-B subtype genetic forms into Western countries. Clin Inf Dis 32:1732–1737CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2003

Authors and Affiliations

  • Giampiero Carosi
  • Francesco Castelli

There are no affiliations available

Personalised recommendations